Proteomics

Dataset Information

0

Plasma proteomics of BACE2 KO mice

ABSTRACT: The beta-secretase BACE1 is a central drug target for Alzheimer’s disease. Clinically tested, BACE1-directed inhibitors also block the homologous protease BACE2. Yet, little is known about physiological BACE2 substrates and functions in vivo. Here, we performed discovery proteomics to identify substrates of the protease BACE2 in plasma of mice. Therefore, we analysed plasma from BACE2 KO, and WT controls. Inactivation of BACE2 inhibited shedding of VEGFR3/FLT4. Thus, sVEGFR3 represents a pharmacodynamic plasma marker for BACE2 activity in vivo.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Blood Plasma

SUBMITTER: Stephan Mueller  

LAB HEAD: Stefan F. Lichtenthaler

PROVIDER: PXD041579 | Pride | 2024-06-27

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
BACE2_plasma_analysis.zip Other
KO1.raw Raw
KO2.raw Raw
KO3.raw Raw
KO4.raw Raw
Items per page:
1 - 5 of 14
altmetric image

Publications

The β-secretase β-site APP cleaving enzyme (BACE1) is a central drug target for Alzheimer's disease. Clinically tested, BACE1-directed inhibitors also block the homologous protease BACE2. Yet little is known about physiological BACE2 substrates and functions in vivo. Here, we identify BACE2 as the protease shedding the lymphangiogenic vascular endothelial growth factor receptor 3 (VEGFR3). Inactivation of BACE2, but not BACE1, inhibited shedding of VEGFR3 from primary human lymphatic endothelial  ...[more]

Similar Datasets

Proteomics Plasma proteomics of mice treated with BACE inhibitors
2024-06-27 | PXD042669 | Pride
Proteomics Plasma proteomics of BACE1, 2, and double KO mice
2024-06-27 | PXD041577 | Pride
Transcriptomics Expression profiling in extracellular miRNAs (plasma miRNAs) of CML patients after imatinib discontinuation (STOP-IM)
2016-03-31 | E-GEOD-75391 | biostudies-arrayexpress
Proteomics The human host response to monkeypox infection: a proteomic case series study
2022-09-22 | PXD036074 | Pride
Transcriptomics Expression profiling in extracellular miRNAs (exosomal miRNAs) of CML patients after imatinib discontinuation (STOP-IM)
2016-03-31 | E-GEOD-75389 | biostudies-arrayexpress
Proteomics Secretome Analysis of hippocampal and cortical murine neurons
2020-09-25 | PXD020503 | Pride
Proteomics Quantitative secretome analysis using improved secretome-protein-enrichment-with-click-sugars method (iSPECS) establishes the cell type-resolved mouse brain glyco-secretome
2020-09-25 | PXD018171 | Pride
Proteomics The proteomic landscape of patient-derived CD4+ T cells in recent-onset type 1 diabetes
2017-11-30 | PXD007184 | Pride
Proteomics Pharmacoproteomics of non-human primate cerebrospinal fluid after BACE inhibition
2023-02-23 | PXD035141 | Pride
Proteomics Surface glycoproteome of BACE1-inhibited neurons
2018-05-08 | PXD008619 | Pride